Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults

OBJECTIVE: Both sodium–glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA) demonstrated cardiovascular benefits in randomized controlled trials of patients with type 2 diabetes (T2D) generally <65 years old and mostly with cardiovascular disease. We...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Care
Main Authors: Patorno, Elisabetta, Pawar, Ajinkya, Bessette, Lily G., Kim, Dae H., Dave, Chintan, Glynn, Robert J., Munshi, Medha N., Schneeweiss, Sebastian, Wexler, Deborah J., Kim, Seoyoung C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2021
Assuntos:
Cardiovascular and Metabolic Risk
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7896266/
https://ncbi.nlm.nih.gov/pubmed/33495295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-1464
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados